This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kulasingam, S. L. Articles by Matchar, D. B. Search for Related Content PubMed PubMed Citation Articles by Kulasingam, S. L. Articles by Matchar, D. B. Social Bookmarking                         What's this?

Linking dementia research to policy: An example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment

Center for Clinical Health Policy Research, Duke Evidence-Based Practice Center, and Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina

Gregory P. Samsa, PhD

Center for Clinical Health Policy Research, Duke Evidence-Based Practice Center, and Department of Medicine, Duke University Medical Center, Durham, North Carolina

David B. Matchar, MD

Center for Clinical Health Policy Research, Duke Evidence-Based Practice Center, Department of Community and Family Medicine, Duke University Medical Center, and Department of Veterans Affairs Medical Center, Durham, North Carolina

References

• 1. NCA Tracking Sheet for Positron Emission Tomography (FDG) and Other Neuroimaging Devices for Suspected Dementia (CAG- 00088R). Available online at: https://www.cms.hhs.gov/mcd/viewtrackingsheet.asp?id=104.
• 2. Matchar DM, Kulasingam SL, McCrory DC, et al.: Use of positron emission tomography and other neuroimaging techniques in the diagnosis and management of Alzheimer's disease and dementia: Task Order No. 7. Prepared by Duke University under Contract No. 290-97-0014. Rockville, MD: Agency for Health Care Policy and Research, February 2002. Available online at: http.:www.cms.hhs.gov/coveragedownload/id64.pdf.
• 3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC; American Psychiatric Association, 1994.
• 4. Small GW, Rabins PV, Barry PP, et al.: Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association and the American Geriatrics Society. JAMA. 1997; 278: 1363-1371.[Abstract/Free Full Text]
• 5. McKhann G. Drachman D, Folstein M, et al.: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984; 34: 939-944.[Abstract/Free Full Text]
• 6. Knopman DS, DeKosky ST, Cummings JL, et al.: Practice parameter: Diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56: 1143-1153.[Abstract/Free Full Text]
• 7. Hoffman JM, Welsh-Bohmer KA, Hanson M, et al.: FDG PET imaging in patients with pathologically verified dementia. J Nucl Med. 2000; 41: 1920-1928.[Abstract/Free Full Text]
• 8. Bookheimer SY, Strojwas MH, Cohen MS, et al.: Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med. 2000; 343: 450-456.[Abstract/Free Full Text]
• 9. Silverman DH, Small GW, Chang CY, et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA. 2001; 286: 2120-2127.[Abstract/Free Full Text]
• 10. Small GW, Ercoli LM, Silverman DH, et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci USA. 2000; 97: 6037-6042.[Abstract/Free Full Text]
• 11. Kulasingam SL, Samsa GP, Zarin DA, et al. When should functional neuroimaging techniques be used in the diagnosis and management of Alzheimer's dementia? A decision-analysis. Value Health. 2003; 6: 542-550.[CrossRef][Medline] [Order article via Infotrieve]
• 12. Doody RS, Stevens JC, Beck C, et al.: Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56: 1154-1166.[Abstract/Free Full Text]
• 13. Tunis SR, Stryer DB, Clancy CM: Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003; 290: 1624-1632.[Abstract/Free Full Text]

American Journal of Alzheimer's Disease and Other Dementias®, Vol. 21, No. 2, 73-78 (2006)
DOI: 10.1177/153331750602100203


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S. R. Tunis and S. D. Pearson Coverage Options For Promising Technologies: Medicare's 'Coverage With Evidence Development' Health Aff., September 1, 2006; 25(5): 1218 - 1230. [Abstract] [Full Text] [PDF]

This Article Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kulasingam, S. L. Articles by Matchar, D. B. Search for Related Content PubMed PubMed Citation Articles by Kulasingam, S. L. Articles by Matchar, D. B. Social Bookmarking                         What's this?